Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Verapamil matches beta-blockers for mild-moderate hypertension with airways safety; extends calcium antagonist options for patients intolerant to beta-blockers.
The calcium antagonist drug, verapamil, was compared in double-blind, double-dummy, crossover studies with two beta-adrenoceptor blocking drugs, pindolol and labetalol. All were equally effective as antihypertensive drugs in patients with mild-to-moderate hypertension. Verapamil caused a fall in blood pressure by reducing total peripheral resistance, as judged by echocardiographic studies, and had no adverse effects on airways resistance in patients with obstructive airways disease. The favorable hemodynamic effects and absence of serious side effects suggest that verapamil may be an important advance in the treatment of hypertension.
No takes yet. Share an insight, caveat, or question.
A. E. Doyle (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: